1. 1. World Health Organization (WHO). Global tuberculosis report 2016. Available at URL: http://www.who.int/tb/publications/global_report/en/. Accessed on 22 April 2017.
2. 2. Central TB Division. Guidelines on programmatic management of drug resistant TB (PMDT) in India. India: Directorate General of Health Services, MoHFW. 2012.
3. 3. Jain K, Desai M, Solanki R, Dikshit RK. Treatment outcome of standardized regimen in patients with multidrug resistant tuberculosis. J Pharmacol Pharmacother 2014;5:145–9.
4. 4. Patel SV, Nimavat KB, Alpesh PB, Shukla LK, Shringarpure KS, Mehta KG, et al. Treatment outcome among cases of multidrug-resistant tuberculosis (MDR TB) in Western India: a prospective study. J Infect Public Health 2016;9:478–84.
5. 5. Arora V, Sarin R, Singla R, Khalid UK, Mathuria K, Singla N, et al. DOTS-Plus for patients with multidrug-resistant tuberculosis in India: early results after three years. Indian J Chest Dis Allied Sci 2007;49:75–9.